These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31434405)

  • 1. [The value of Clermont score in detection intestinal mucosal ulcer of Crohn's disease].
    Ye YX; Ju SS; Huang W; Lin WW
    Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(29):2293-2296. PubMed ID: 31434405
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging is effective to detect ileocolonic ulcerations in Crohn's disease.
    Buisson A; Hordonneau C; Goutte M; Boyer L; Pereira B; Bommelaer G
    Aliment Pharmacol Ther; 2015 Aug; 42(4):452-60. PubMed ID: 26088810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance index of activity (MaRIA) and Clermont score are highly and equally effective MRI indices in detecting mucosal healing in Crohn's disease.
    Buisson A; Pereira B; Goutte M; Reymond M; Allimant C; Obritin-Guilhen H; Bommelaer G; Hordonneau C
    Dig Liver Dis; 2017 Nov; 49(11):1211-1217. PubMed ID: 28919192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ileal Crohn's disease response to TNF antagonists: Validation of MR enterography for assessing response. Initial results.
    Gordic S; Bane O; Kihira S; Peti S; Hectors S; Torres J; Cho J; Colombel JF; Taouli B
    Eur J Radiol Open; 2020; 7():100217. PubMed ID: 33102636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease.
    Buisson A; Joubert A; Montoriol PF; Da Ines D; Hordonneau C; Pereira B; Garcier JM; Bommelaer G; Petitcolin V
    Aliment Pharmacol Ther; 2013 Mar; 37(5):537-45. PubMed ID: 23289713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three magnetic resonance enterography indices for grading activity in Crohn's disease.
    Rimola J; Alvarez-Cofiño A; Pérez-Jeldres T; Ayuso C; Alfaro I; Rodríguez S; Ricart E; Ordás I; Panés J
    J Gastroenterol; 2017 May; 52(5):585-593. PubMed ID: 27599973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity.
    Hordonneau C; Buisson A; Scanzi J; Goutorbe F; Pereira B; Borderon C; Da Ines D; Montoriol PF; Garcier JM; Boyer L; Bommelaer G; Petitcolin V
    Am J Gastroenterol; 2014 Jan; 109(1):89-98. PubMed ID: 24247212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early transmural healing and its predictors assessed by magnetic resonance enterography in patients with Crohn's disease receiving ustekinumab.
    Zhou L; Hu C; Zhang R; Qiu Y; Wang Y; Liu Z; Chen B; He Y; Zeng Z; Li X; Mao R; Chen M
    Therap Adv Gastroenterol; 2023; 16():17562848231170947. PubMed ID: 37168404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted magnetic resonance imaging without bowel preparation for detection of ulcerative colitis.
    Yu LL; Yang HS; Zhang BT; Lv ZW; Wang FR; Zhang CY; Chen WB; Zhang HM
    World J Gastroenterol; 2015 Sep; 21(33):9785-92. PubMed ID: 26361426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative apparent diffusion coefficient (ADC) values as an imaging biomarker for fibrosis in pediatric Crohn's disease: preliminary experience.
    Kovanlikaya A; Beneck D; Rose M; Renjen P; Dunning A; Solomon A; Sockolow R; Brill PW
    Abdom Imaging; 2015 Jun; 40(5):1068-74. PubMed ID: 25248794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI Enables to Accurately Grade Inflammatory Activity in Patients of Ileocolonic Crohn's Disease: Results from an Observational Study.
    Li XH; Sun CH; Mao R; Huang SY; Zhang ZW; Yang XF; Huang L; Lin JJ; Zhang J; Ben-Horin S; Feng ST; Chen MH; Li ZP
    Inflamm Bowel Dis; 2017 Feb; 23(2):244-253. PubMed ID: 28079618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal diffusion-weighted imaging changes in children with small bowel Crohn's disease: preliminary experience.
    Rosenbaum DG; Rose ML; Solomon AB; Giambrone AE; Kovanlikaya A
    Abdom Imaging; 2015 Jun; 40(5):1075-80. PubMed ID: 25808716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADC Values for Detecting Bowel Inflammation and Biologic Therapy Response in Patients With Crohn Disease: A Post Hoc Prospective Trial Analysis.
    Rimola J; Fernandez-Clotet A; Capozzi N; Caballol B; Rodríguez S; Gallego M; Masamunt MC; Panés J; Ricart E; Ordás I
    AJR Am J Roentgenol; 2024 Jan; 222(1):e2329639. PubMed ID: 37584507
    [No Abstract]   [Full Text] [Related]  

  • 15. Diffusion-weighted magnetic resonance for assessing ileal Crohn's disease activity.
    Caruso A; DʼIncà R; Scarpa M; Manfrin P; Rudatis M; Pozza A; Angriman I; Buda A; Sturniolo GC; Lacognata C
    Inflamm Bowel Dis; 2014 Sep; 20(9):1575-83. PubMed ID: 25025715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted imaging and apparent diffusion coefficient values for evaluating terminal ileitis in patients with Crohn's disease.
    Durayski E; Watte G; Pacini GS; Roman DH; Machado MB; Marchiori E; Hochhegger B; Baldisserotto M
    Radiol Bras; 2019; 52(6):361-367. PubMed ID: 32047329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted magnetic resonance for assessing fibrosis in Crohn's disease.
    Caruso A; Angriman I; Scarpa M; D'Incà R; Mescoli C; Rudatis M; Sturniolo GC; Schifano G; Lacognata C
    Abdom Radiol (NY); 2020 Aug; 45(8):2327-2335. PubMed ID: 31392397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.
    Baillet P; Cadiot G; Goutte M; Goutorbe F; Brixi H; Hoeffel C; Allimant C; Reymond M; Obritin-Guilhen H; Magnin B; Bommelaer G; Pereira B; Hordonneau C; Buisson A
    World J Gastroenterol; 2018 Feb; 24(5):641-650. PubMed ID: 29434453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion kurtosis MRI versus conventional diffusion-weighted imaging for evaluating inflammatory activity in Crohn's disease.
    Huang L; Li XH; Huang SY; Zhang ZW; Yang XF; Lin JJ; Jiang MJ; Feng ST; Sun CH; Li ZP
    J Magn Reson Imaging; 2018 Mar; 47(3):702-709. PubMed ID: 28577319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn's disease.
    Kopylov U; Klang E; Yablecovitch D; Lahat A; Avidan B; Neuman S; Levhar N; Greener T; Rozendorn N; Beytelman A; Yanai H; Dotan I; Chowers Y; Weiss B; Ben-Horin S; Amitai MM; Eliakim R;
    Therap Adv Gastroenterol; 2016 Sep; 9(5):655-63. PubMed ID: 27582877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.